211 related articles for article (PubMed ID: 31572392)
1. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
Front Immunol; 2019; 10():2185. PubMed ID: 31572392
[TBL] [Abstract][Full Text] [Related]
2. Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy.
Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portalès P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Sotto A; Sabatier R; Winter A; Fabbro P; Vincent T; Reynes J; Corbeau P
Front Immunol; 2021; 12():663843. PubMed ID: 33859653
[TBL] [Abstract][Full Text] [Related]
3. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
4. One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.
Psomas C; Younas M; Reynes C; Cezar R; Portalès P; Tuaillon E; Guigues A; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Marin G; Nagot N; Sotto A; Eliaou JF; Sabatier R; Reynes J; Corbeau P
EBioMedicine; 2016 Jun; 8():265-276. PubMed ID: 27428436
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutiérrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
Medicine (Baltimore); 2015 May; 94(17):e781. PubMed ID: 25929922
[TBL] [Abstract][Full Text] [Related]
6. Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation.
Torres B; Guardo AC; Leal L; Leon A; Lucero C; Alvarez-Martinez MJ; Martinez MJ; Vila J; Martínez-Rebollar M; González-Cordón A; Gatell JM; Plana M; García F
J Int AIDS Soc; 2014; 17(1):19246. PubMed ID: 25280865
[TBL] [Abstract][Full Text] [Related]
7. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
Abad-Fernández M; Gutiérrez C; Madrid N; Hernández-Novoa B; Díaz L; Muñoz-Fernández MA; Moreno S; Vallejo A
HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
[TBL] [Abstract][Full Text] [Related]
8. Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.
Younas M; Psomas C; Reynes J; Corbeau P
HIV Med; 2016 Feb; 17(2):89-105. PubMed ID: 26452565
[TBL] [Abstract][Full Text] [Related]
9. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
[TBL] [Abstract][Full Text] [Related]
10. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
11. The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation.
Van de Wijer L; van der Heijden WA; Ter Horst R; Jaeger M; Trypsteen W; Rutsaert S; van Cranenbroek B; van Rijssen E; Joosten I; Joosten L; Vandekerckhove L; Schoofs T; van Lunzen J; Netea MG; Koenen HJPM; van der Ven AJAM; de Mast Q
Front Immunol; 2021; 12():661990. PubMed ID: 33953724
[TBL] [Abstract][Full Text] [Related]
12. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy.
Erlandson KM; Allshouse AA; Jankowski CM; Lee EJ; Rufner KM; Palmer BE; Wilson CC; MaWhinney S; Kohrt WM; Campbell TB
J Infect Dis; 2013 Jul; 208(2):249-59. PubMed ID: 23559466
[TBL] [Abstract][Full Text] [Related]
13. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy.
Taiwo B; Hunt PW; Gandhi RT; Ellingson A; McKenna M; Jacobson JM; Gripshover B; Bosch RJ
J Acquir Immune Defic Syndr; 2013 May; 63(1):101-4. PubMed ID: 23392463
[TBL] [Abstract][Full Text] [Related]
15. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.
Marchetti G; Bellistrì GM; Borghi E; Tincati C; Ferramosca S; La Francesca M; Morace G; Gori A; Monforte AD
AIDS; 2008 Oct; 22(15):2035-8. PubMed ID: 18784466
[TBL] [Abstract][Full Text] [Related]
16. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
Karlsson AC; Younger SR; Martin JN; Grossman Z; Sinclair E; Hunt PW; Hagos E; Nixon DF; Deeks SG
AIDS; 2004 Apr; 18(7):981-9. PubMed ID: 15096800
[TBL] [Abstract][Full Text] [Related]
17. Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.
Ramendra R; Isnard S; Mehraj V; Chen J; Zhang Y; Finkelman M; Routy JP
Front Immunol; 2019; 10():465. PubMed ID: 30967860
[TBL] [Abstract][Full Text] [Related]
18. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
[TBL] [Abstract][Full Text] [Related]
19. Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV.
Fitzgerald FC; Lhomme E; Harris K; Kenny J; Doyle R; Kityo C; Shaw LP; Abongomera G; Musiime V; Cook A; Brown JR; Brooks A; Owen-Powell E; Gibb DM; Prendergast AJ; Sarah Walker A; Thiebaut R; Klein N;
J Infect Dis; 2019 Jan; 219(1):89-100. PubMed ID: 30107546
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.
Tenorio AR; Chan ES; Bosch RJ; Macatangay BJ; Read SW; Yesmin S; Taiwo B; Margolis DM; Jacobson JM; Landay AL; Wilson CC;
J Infect Dis; 2015 Mar; 211(5):780-90. PubMed ID: 25214516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]